These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial. Gutierrez JA; Karwatowska-Prokopczuk E; Murphy SA; Belardinelli L; Farzaneh-Far R; Walker G; Morrow DA; Scirica BM Clin Cardiol; 2015 Aug; 38(8):469-75. PubMed ID: 26059896 [TBL] [Abstract][Full Text] [Related]
24. Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation). Fearon WF; Nishi T; De Bruyne B; Boothroyd DB; Barbato E; Tonino P; Jüni P; Pijls NHJ; Hlatky MA; Circulation; 2018 Jan; 137(5):480-487. PubMed ID: 29097450 [TBL] [Abstract][Full Text] [Related]
25. Achieving Optimal Medical Therapy: Insights From the ORBITA Trial. Foley M; Rajkumar CA; Shun-Shin M; Ganesananthan S; Seligman H; Howard J; Nowbar AN; Keeble TR; Davies JR; Tang KH; Gerber R; O'Kane P; Sharp ASP; Petraco R; Malik IS; Nijjer S; Sen S; Francis DP; Al-Lamee R J Am Heart Assoc; 2021 Feb; 10(3):e017381. PubMed ID: 33496201 [TBL] [Abstract][Full Text] [Related]
26. Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention. Lu Y; Zhang H; Wang Y; Zhou T; Welsh J; Liu J; Guan W; Li J; Li X; Zheng X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L JAMA Netw Open; 2018 Dec; 1(8):e185446. PubMed ID: 30646292 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial. Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561 [TBL] [Abstract][Full Text] [Related]
37. De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status. Qintar M; Hirai T; Arnold SV; Sheehy J; Sapontis J; Jones P; Tang Y; Lombardi W; Karmpaliotis D; Moses J; Patterson C; Nicholson WJ; Cohen DJ; Spertus JA; Grantham JA; Salisbury AC Am Heart J; 2019 Aug; 214():1-8. PubMed ID: 31152872 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of Sodium Tanshinone IIA Sulfonate in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Controlled, Randomized Trial. Mao S; Wang L; Zhao X; Guo L; Lin Q; Wang X; Dai X; Shang H; Zhang M; Hinek A Cardiovasc Drugs Ther; 2021 Apr; 35(2):321-329. PubMed ID: 32940893 [TBL] [Abstract][Full Text] [Related]
39. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Xu B; Tu S; Song L; Jin Z; Yu B; Fu G; Zhou Y; Wang J; Chen Y; Pu J; Chen L; Qu X; Yang J; Liu X; Guo L; Shen C; Zhang Y; Zhang Q; Pan H; Fu X; Liu J; Zhao Y; Escaned J; Wang Y; Fearon WF; Dou K; Kirtane AJ; Wu Y; Serruys PW; Yang W; Wijns W; Guan C; Leon MB; Qiao S; Stone GW; Lancet; 2021 Dec; 398(10317):2149-2159. PubMed ID: 34742368 [TBL] [Abstract][Full Text] [Related]